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Streptomyces species are rare causes of invasive infection in humans. We
report the first documented case of a catheter-associated bacteremia due to
Streptomyces. The most likely source of infection was unlicensed, injectable
holistic preparations that the patient had received. We review reported
cases of invasive infections caused by Streptomyces and comment on the
potential infectious complications of parenteral holistic treatments. 
Streptomyces species are aerobic actinomycetes best
known for their production of antimicrobial substances. They
infrequently cause human disease, most often manifesting
as a localized, chronic suppurative infection of the skin and
underlying soft tissue (1). Nonmycetomic infections caused
by Streptomyces species are very rare.
We report the first documented case of a catheter-associ-
ated bacteremia caused by  Streptomyces. The most likely
source of infection was unlicensed, injectable holistic prepa-
rations that the patient had received. Identifying the use of
alternative medicines by patients may be essential in evalu-
ating cases or outbreaks of new or unusual organisms.
 Case Report
A 49-year-old African-American woman had a 10-year
history of breast cancer, for which she had declined chemo-
therapy; she opted to receive holistic treatments only. Her
disease progressed; she underwent bilateral mastectomies
and bone metastases developed. Approximately 1 year before
admission, the patient had a subcutaneous central venous
catheter placed to receive intravenous infusions of holistic
preparations.
She reportedly received infusions of glutathion, germa-
nium, superoxide dismutase, interferon (100,000 IU), man-
ganese, selenium, zinc, magnesium chloride, calcium
gluconate, potassium chloride, and vitamin C (25 g), as well
as “NeyTumorin,” a holistic preparation (2). 
Three weeks before admission, the patient complained
of feeling feverish after receiving an infusion at her pro-
vider’s office. Her temperature was 38°C. Blood drawn
through the subcutaneous catheter was sent for culture and
was reported as growing “diphtheroids.” Eleven days later,
repeat blood cultures drawn through the catheter grew
gram-positive bacilli, which a laboratory could not identify
further. At that time the patient was referred to our hospital
for admission.
The patient’s medications at the time of admission were
pamidronate, a multivitamin, and the holistic infusions. She
had no history of alcohol or illicit drug use. She denied HIV
risk factors but had never been tested for HIV. She had not
traveled recently and had no remarkable animal exposures.
She had previously worked as a nurse.
On examination, she appeared nontoxic; her blood pres-
sure was 143/83 mmHg, heart rate was 84 beats per minute,
respiratory rate was 16, and temperature was 37.3°C. Physi-
cal examination revealed a subcutaneous port in her right
anterior chest, which showed no signs of infection; well-
healed bilateral mastectomy scars; and a grade II/VI systolic
heart murmur.
After blood had been drawn for cultures, the patient was
started empirically on vancomycin. Blood drawn peripher-
ally and through the subcutaneous catheter on hospital days
1, 2, and 3 grew gram-positive elongated bacilli in the aero-
bic culture bottles. Her central venous catheter was removed
on the fourth hospital day. Culture of the catheter tip was
negative. A transthoracic echocardiogram showed no valvu-
lar vegetations.
When examined directly from liquid media, the organ-
ism appeared as long, branching, beaded, gram-positive
bacilli. However, the organism grown on agar plates
appeared more fragmented, as single, gram-positive bacilli.
The isolate was catalase positive and modified acid-fast neg-
ative; aerial mycelia were present. There was no growth in
lysozyme. The organism also hydrolyzed casein, xanthine,
and tyrosine and yielded positive starch, gelatin, nitrate,
and esculin reactions. Our laboratory identified the organ-
ism as a Streptomyces species. This isolate was sent to the
Centers for Disease Control and Prevention (CDC) for confir-
mation of identification, and cell-wall analysis identified the
peptidoglycan L-diaminopimelic acid, confirming that the
isolate was a member of the genus Streptomyces (3).
The antibiotic regimen used to treat the patient was
changed to intravenous ceftriaxone, 1 g every 24 hours, and
oral clarithromycin, 500 mg twice a day. Her fever resolved,
and she remained asymptomatic; repeat blood cultures were
negative. A percutaneous indwelling central catheter was
placed, and the patient was discharged to home with
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recommendations to complete a 1-month course of ceftriax-
one and a 6-month course of clarithromycin.
Three months after hospital discharge, the patient had
no evidence of residual infection, and repeat blood cultures
were negative. She was subsequently admitted to the pallia-
tive care unit for management of pain due to diffuse bone
metastases and eventually died.
Conclusions
The most common manifestation of Streptomyces infec-
tion, mycetoma, typically results from inoculation of the
microorganism through an injury caused by a thorn and usu-
ally involves the legs and feet (4). Invasive  Streptomyces
infections are extremely rare. A Medline search from 1966 to
2000 identified only 10 cases of invasive Streptomyces infec-
tion, defined as infection other than mycetoma or superficial
skin infections (1,5); in none of the cases was infection
caused by catheter-associated sepsis. Previous cases
included four cases of pneumonia and one each of lymphad-
enitis, pericarditis, brain abscess, peritonitis, endocarditis,
and intraspinal mycetoma. Five of the patients had underly-
ing conditions identified: four were HIV infected, and one
had a prosthetic aortic valve. In only two of the nine cases
(one of pneumonia and one of endocarditis) was Streptomyces
cultured from the blood.
Treatment recommendations for Streptomyces infections
are generally based on in vitro data and analogies from data
on the treatment of  Nocardia  infections (1). McNeil et al.
performed in vitro tests of the susceptibility of aerobic acti-
nomycetes species, including 28 isolates of  S. griseus
referred to CDC from October 1985 to February 1988 (6).
These data suggest that the best antimicrobial options for
visceral Streptomyces  infection include macrolides, minocy-
cline, doxycycline, ceftriaxone, and imipenem (6). Twenty-
nine percent of S. griseus species tested at CDC were resis-
tant to trimethoprim/sulfamethoxazole, the drug of choice
for treatment of Nocardia infections (6). 
A variety of antimicrobial regimens were used in the
previously reported cases, and in most the outcome was
good, with resolution of infection. However, the optimal
choice of antimicrobial agent and duration of therapy for
Streptomyces visceral infections remain to be determined. 
Our patient had clearance of bacteremia after removal
of the indwelling central catheter and a course of ceftriaxone
and clarithromycin. While the catheter tip culture was nega-
tive and hence an alternate focus cannot be entirely
excluded, the patient’s fever resolved and blood cultures
promptly cleared after catheter removal, supporting the
inference that the infection was catheter associated. 
The previous reports of invasive Streptomyces disease do
not mention putative sources of the infections. For our
patient, who had no history of travel or unusual agricultural
exposures, a possible source of infection was the unlicensed,
injectable holistic preparations that she had received.
Attempts to obtain samples of the intravenous holistic prep-
arations for culture were unsuccessful, as were attempts to
assess whether other patients had received this preparation
and whether any other infectious complications had
occurred. Information on any measures used to ensure prod-
uct sterility was unavailable. 
Three times a week, our patient was receiving infusions
of a preparation that included a compound called
NeyTumorin, which reportedly consists of “a combination of
peptides and proteins of 15 different organs from fetal and
young pigs or cows” (2). The inventor of NeyTumorin claims
that “physiologic repair aids” from the cytoplasm of healthy
animal organs result in immunogenic and immunomodula-
tory effects that improve a patient’s biologic response to
malignancy (2). However, the specific components of NeyTu-
morin are not defined, the claimed mechanism of action has
not been proven, and there is no evidence of clinical efficacy.
Clinical studies are described as inconclusive “because of
false or insufficient documentation” (2).
The use of alternative and herbal medicines in the
United States has increased steadily over the past decade
(7,8). Patients frequently believe that if a substance is “natu-
ral,” it is safe; likewise, providers often assume that such
substances are unlikely to be harmful (9). However, recent
data have demonstrated that some holistic medicines may
result in a variety of undesirable effects. Acute rejection has
been reported in two heart transplant patients due to a met-
abolic interaction between cyclosporine and St. John’s wort
(Hypericum perforatum), which induces the 3A4 isoform of
the cytochrome P450 enzyme system (10). Through a similar
drug-to-drug interaction, St. John’s wort has been shown to
lower plasma levels of the protease inhibitor indinavir,
potentially placing patients at risk for antiretroviral resis-
tance and treatment failure (9).
Alternative remedies may also directly cause adverse
drug effects; interfere with laboratory assays; contain unrec-
ognized, potentially harmful contaminants; and, if nonster-
ile, transmit infections (9-11). Distribution of an unlicensed
injectable preparation, purported to contain adrenal cortex
extract contaminated with Mycobacterium abscessus, led to a
multistate outbreak of soft-tissue abscesses (11). Our case
may represent another instance of an infection transmitted
by the injectable use of a holistic preparation.
To create an environment that is conducive to open com-
munication and education, physicians should discuss alter-
native therapies nonjudgmentally with patients to identify
what substances patients may be using (7). Given the
increased use of alternative medicines, including those
administered parenterally, increased vigilance in monitoring
patients for potential infectious complications of such treat-
ments is needed. Clinicians should be aware of data address-
ing the safety and efficacy of alternative and herbal
preparations and of reliable data sources such as the
National Institutes of Health’s National Center for Comple-
mentary and Alternative Medicine (nccam.nih.gov) and the
Office of Dietary Supplements (odp.od.nih.gov/ods).
Dr. Carey is an infectious diseases attending physician at Beth
Israel Medical Center in New York, Her research interests include
the metabolic complications of HIV antiretroviral therapy.
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